British American Tobacco's Btomorrow Ventures Leads $25.4M Series A For Cannabinoid Biotech Co. Trait Bio
Trait Biosciences, a leading cannabinoid biotechnology research organization, announced that it has completed a C$31 million ($25.46 million) Series A financing round led by the corporate venturing unit of British American Tobacco (NYSE: BTI), Btomorrow Ventures, and backed by Gotham Green Partners.
